Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucocorticoid Treatment in Patients Undergoing TAVR to Reduce the Incidence of Atrioventricular Block and Pacemaker Implantation

NCT06076824 is registered in ClinicalTrials.gov with Hospital General Universitario de Alicante as lead sponsor.

NCT NCT06076824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06076824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucocorticoid Treatment in Patients Undergoing TAVR to Reduce the Incidence of Atrioventricular Block and Pacemaker Implantation
Lead sponsor
Hospital General Universitario de Alicante
Phase
Phase 4
Overall status
Unknown status
Start date
August 12, 2023
Completion date
September 1, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, bundle-branch block, heart block